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The P97/302 field outbreak isolate was identified as a very virulent infectious 
bursal disease virus (vvIBDV) of serotype 1 ,  based on the conventional and 
molecular characterization methods. The high mortality, gross and 
histopathological lesions observed during the outbreak and in the experimental 
infected SPF chickens induced by P97/302 IBDV isolate were characteristics of 
vvIBDV strain reported previously. The sequence of P97/302 isolate has amino 
acid substitutions at 222(A), 256(1), 294(1) and 299(S) similar to other reported 
vvIBDV. This isolate does not have 249(K) and 2S4(S) amino acid residues which 
have been reported to be present in variant strains. The amino acid residues of the 
P97/302 at the two hydrophilic regions and the serine-rich heptapeptide region are 
the same as reported for vv strains of UK66 1 ,  HK46 and OKYM. The P97/302 
IBDV isolate can be digested with Taq1 ,  Acel, Sty1 ,  Spel enzymes and not with 
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Sac1 as reported for other vv IBDV. This isolate is most homologous to the 
reported vv IBDV strains especially UK661. Phylogenetic analysis based on the 
nucleotide sequence of the hypervariable region revealed that P97/302 IBDV 
isolate can be clustered with the vvIBDV strains and is distinct from classical, 
variant and attenuated strains. Using this P97/302 IBDV local isolate, the study 
has successfully developed three diagnostic tools for antibody and antigen 
detection. They are the indirect, double antibody sandwich (DAS) and reverse­
transcription (RT) nested polymerase chain reaction (PCR) enzyme-linked 
immunoassay assay (ELISA). The developed indirect and DAS ELISA are based 
on the use of regression equation line which generated from the standard curves to 
measure IBD antibody titre. They are highly significant correlated (p< 0.0 1 )  when 
compared with IDEXX commercial ELISA. They are more advantage than the 
commercial kits whereby the local isolate was used for the ELISA coating which 
was able to enhance the accuracy to predict the protection to IBD. The developed 
DAS ELISA for antigen detection is also highly specific. The developed RT 
nested PCR was highly specific and ten times more sensitive when compared to 
conventional RT/PCR. The RT nested PCR ELISA method was also highly 
specific and hundred times more sensitive when compared to conventional 
RTIPCR with agarose gel electrophoresis detection method. It was concluded that 
the P97/302 local isolate was vvIBDV strain and the developed indirect, DAS and 
RT nested PCR ELISA are potentially used for monitoring and screening large 
number of samples for antibody and antigen detection from chicken flocks. 
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P97/302 strain dari ladang ayam telah dikenalpasti sebagai serotip 1 VIruS 
penyakit bursa berjangkit yang amat virulen (vvIBDV) berdasarkan pencirian cara 
konvensional dan molekul . Kadar kematian yang tinggi, lesi-lesi patologi dan 
histopatologi semasa outbreak dan pada ayam bebas-patogen khusus (SPF) telah 
mencirikannya sebagai vvIBDV seperti yang pernah dilaporkan. Jujukan P97/302 
mempunyai penggantian asid amino di kedudukan 222(A), 256(1), 294(1) dan 
299(S) seperti yang dilaporkan pada vvIBDV yang lain. P97/302 tidak 
mempunyai asid amino residu di kedudukan 249(K) dan 254(S) seperti yang 
dilaporkan pada strain varian. Ia mempunyai asid amino residu yang sarna dengan 
vvIBDV yang lain iaitu UK66 1 ,  HK46 dan OKYM, di dua kawasan hidrofilik 
dan kawasan heptapeptid yang kay a dengan serine. Ia boleh dicernakan oleh 
enzim pembatas Taq 1, Ace 1, Sty 1, Spe 1 dan tidak pula oleh Sacl sepertimana 
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yang dilaporkan pada vvIBDV yang lain. P97/302 sangat homologi dengan 
vvlBDV lain yang dilaporkan, terutamanya dengan UK66 1 .  Analisis filogenesis 
berdasarkan kawasan hiper boleh ubah jujukan nukleotid menunjukkan strain ini 
sekumpulan dengan vvIBDV dan berlainan kumpulan dengan strain-strain klasik, 
varian dan attenuated. Dengan menggunakan P97/302 IBDV, kaj ian ini telah 
berjaya membuat tiga jenis alat diagnosa untuk mengesan antibodi dan antigen. 
Alat-alat ini ialah indirect, double antibodi sandwich (DAS) dan reverse­
transkripsi (RT) nested reaksi rantaian polimerasi (peR) asai immunoerap 
terangkai enzim (ELISA). Indirect dan DAS ELISA ini adalah berdasarkan 
penggunaan formula regressi yang dibentuk dari garis standard untuk mengukur 
antibodi IBD titer. Alat-alat ini menunjukkan kolerasi yang sangat ketara (p< 
0 .0 1 )  apabila dibandingkan dengan komersial ELISA IDEXX. Alat-alat ini lebih 
baik daripada ELISA komersial kerana strain tempatan digunakan untuk melapis 
ELISA yang akan meningkatkan ketepatan meramal perlindungan daripada IBD.  
DAS ELISA juga sangat spesifik untuk mengesan antigen. RT nested peR juga 
didapati sangat specifik dan menunjukkan sepuluh kali lebih sensitif apabila 
dibandingkan dengan konvensional RT/PCR. RT nested peR ELISA pula didapati 
sangat spesifik dan telah menunjukkan seratus kali lebih sensitif apabila 
dibandingkan dengan konvensional RT/PCR yang menggunakan agarose gel 
electroforesi. Kesimpulannya, P97/302 strain adalah vvIBDV dan indirect, DAS 
dan RT nested peR ELISA ini adalah berpotensi untuk mengkaj i  dan menyiasat 
sampel antibodi dan antigen dari kelompok ayam. 
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Infectious bursal disease (lBD) is an acute highly contagious viral disease 
in chickens which is caused by IBD virus (IBDV). Lymphoid tissue is the primary 
target organ of IBDV with the special predilection for the bursa of Fabricius. The 
disease was first recognized as a clinical entity in 1 957 in USA by Cosgrove 
( 1 962) and was referred to as 'avian nephrosis' because of the extreme kidney 
damage found in birds that succumbed to infections. Since the first outbreaks of 
IBD in the area of Gumboro, Delaware, "Gumboro disease" was a synonym for 
this disease and is still frequently used. The disease becomes important in poultry 
industry worldwide due to significant economic losses resulting from high 
mortality, impaired growth, excessive carcass condemnation and profound 
immunosuppression which lead to increase susceptibility to other pathogens. The 
disease can interfere the effectiveness of the vaccination programmes against 
other highly virulent disease (Allan, et al., 1 972; Okoye, 1 984). 
Two distinct serotypes of IBDV, designated as serotype 1 and serotype 2 
have been identified. The serotype 1 strains are pathogenic to chickens and vary in 
their virulence, whereas serotype 2 strains, isolated from turkey are apathogenic to 
both turkey and chicken (Lukert and Saif, 1 99 1 ). According to antigenic variation 
and virulence, serotype 1 strains can be divided into several groups: classical 
2 
virulent, attenuated, antigenic variant and very virulent (vv) strains (Cao, et al. , 
1 998). 
Since the first outbreak of IBD in 1 957, the disease was relatively under 
control due to proper immunization programmes in both the parent stock and their 
progeny. In the mid-80's, antigenic and pathogenic serotype 1 ,  variants of IBDV 
were isolated by Saif and Rosenberger (Lukert, 1 995) from the Delmarva area. 
Subsequently, the variants were recognized in other areas of the United States. 
The variant strains were significantly different antigenically to those of classical 
virulent IBDV and they could overcome higher levels of chicken maternal 
antibody within the first week to 1 0  days (Lukert, 1 995). These variant strains 
were also different pathogenically which did not cause clinical disease in older 
chickens (4-6 weeks of age) when compared to the classical strains, but they could 
induce severe bursal atrophy and immunosuppression (Lukert, 1 995). Recently, 
Giambrone (200 1 )  described that the latest IBDV variants to evolve are strains 
that can contribute to infectious proventriculus. However, the evidence of the 
presence of the variant strains of IBD has never been presented in Europe or 
Malaysia. 
In the late 1 980's, outbreaks of clinical IBD with high mortality, up to 
90% due to highly virulent strains of serotype 1 IBDV occurred throughout 
Europe (Chettle, et al. , 1 989; Stuart, 1 989; Van Den Berg, et aI. , 1 99 1 ). The 
disease had spread worldwide and was described in Asia in 1 990's (Nunoya et aI., 
